MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry

Quick Summary:

Features include: Multi-agent orchestration for automating end-to-end workflowsBuilt-in governance and auditability for compliance with HIPAA, GxP, 21 CFR Part 11, and other regulationsPre-trained industry agents for pharma R&D, regulatory operations, clinical trials, and patient servicesEcosystem of 100s of integrations with various third-party systems and data sources The core idea behind the Agentic AI platform emphasizes its capacity to lead industry in transitioning from moving from AI that answers...to AI that achieves, thereby speeding up results and supporting more informed decision-making.

With its forward-thinking "Maxis AI – Drug Development Agency" model and its Intelligent Platform "Designed to Think.Built to Act.," the company helps pharmaceutical, and life sciences organizations achieve smarter, faster insights and more effective processes for superior clinical outcomes.

Whether it’s a clinical data agent or a site monitoring agent, we’re seeing measurable proof of value within weeks of deployment,” said Nicole Powell, Senior Vice President, Business Development at Maxis AI.

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Maxis AI

Category: Technology

Markets: China

Topics: Trials Built Data Agentic Clinical Platform Evolution Maxis Agents Development Designed

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-05-12 @ 13:51:00 (18 hours ago)

News Timezone: GMT +8:00

News Source URL: globenewswire.com

Language: English

Article Length: 586 words

Reading Time: 4 minutes read

Sentences: 25 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © GlobeNewswire

News ID: 28614008

View Article Analysis

About GlobeNewswire

Main Topics: Technology

Official Website: globenewswire.com

Update Frequency: 76 posts per day

Year Established: 1998

Headquarters: China

News Last Updated: 11 hours ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #116

Publisher Details

Frequently Asked Questions